Herrmann, Nathan
Sunnybrook Health Science Centre · University of Toronto
8 papers on CoChatORCID 0000-0001-9955-3155
Most cited papers
- Verified
Blood-brain barrier opening in Alzheimer’s disease using MR-guided focused ultrasound
Lipsman, N., Meng, Y., Bethune, A. J., Huang, Y., Lam, B., Masellis, M., Herrmann, N., Heyn, C., Aubert, I., Boutet, A., et al. (2018) · Nature Communications
Ultrasound and Hyperthermia ApplicationsAlzheimer's disease research and treatments
Cited by 950
- Verified
Peripheral alterations in cytokine and chemokine levels after antidepressant drug treatment for major depressive disorder: systematic review and meta-analysis
Köhler, C. A., Freitas, T. H., Stubbs, B., Maes, M., Solmi, M., Veronese, N., de Andrade, N. Q., Morris, G., Fernandes, B. S., Brunoni, A. R., et al. (2017) · Molecular Neurobiology
Tryptophan and brain disordersTreatment of Major Depression
Cited by 449
- Verified
Functional Neuroanatomical Substrates of Altered Reward Processing in Major Depressive Disorder Revealed by a Dopaminergic Probe
Tremblay, L. K., Naranjo, C. A., Graham, S. J., Herrmann, N., Mayberg, H. S., Hevenor, S., & Busto, U. E. (2005) · Archives of General Psychiatry
Neurotransmitter Receptor Influence on BehaviorNeural and Behavioral Psychology Studies
Cited by 340
- Verified
Probing Brain Reward System Function in Major Depressive Disorder: Altered Response to Dextroamphetamine
Tremblay, L. K., Naranjo, C. A., Cardenas, L., Herrmann, N., & Busto, U. E. (2002) · Archives of General Psychiatry
Neurotransmitter Receptor Influence on BehaviorTreatment of Major Depression
Cited by 229
- Verified
GABAergic Function in Alzheimer's Disease: Evidence for Dysfunction and Potential as a Therapeutic Target for the Treatment of Behavioural and Psychological Symptoms of Dementia
Lanctôt, K. L., Herrmann, N., Mazzotta, P., Khan, L. R., & Ingber, N. (2004) · The Canadian Journal of Psychiatry
Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments
Cited by 191
- Verified
Pharmacological interventions for apathy in Alzheimer's disease
Ruthirakuhan, M. T., Herrmann, N., Abraham, E. H., Chan, S., & Lanctôt, K. L. (2018) · Cochrane Database of Systematic Reviews
Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments
Cited by 113
- Verified
Mild cognitive impairment and major depressive disorder are associated with molecular senescence abnormalities in older adults
Diniz, B. S., Vieira, E. M., Mendes‐Silva, A. P., Bowie, C. R., Butters, M. A., Fischer, C. E., Flint, A., Herrmann, N., Kennedy, J., Lanctôt, K. L., et al. (2021) · Alzheimer's & Dementia: Translational Research & Clinical Interventions
Dementia and Cognitive Impairment ResearchTelomeres, Telomerase, and Senescence
Cited by 33
- Verified
Current agents in development for treating behavioral and psychological symptoms associated with dementia
Ahmed, M., Malik, M., Teselink, J., Lanctôt, K. L., & Herrmann, N. (2019) · Drugs & Aging
Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments
Cited by 29
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free